CClinicalTrials.gg
CompletedNCT06992063Updated May 22, 2026

Evaluation of Post-dural Puncture Headache in Female Patients Undergoing Obstetric and Non-obstetric Surgery

An observational study in Post-Dural Puncture Headache, sponsored by Duzce University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Duzce University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
112
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The goal of this observational study is to compare the incidence, severity, and potential risk factors for Post-dural Puncture headaches (PDPH) in obstetric and non-obstetric female patients undergoing spinal anesthesia. The main questions it aims to answer are:

Are there differences between these two groups? Are there contributing factors? Researchers will compare obstetric and non-obstetric patients to see if pregnancy affects female patients in context of PDPH.

Participants will be monitored periodically for PDPH development. The frequency and severity of headaches will be assessed using the Numerical Rating Scale (NRS) and Wong-Baker Scale. Additionally, the need for medical consultations and any complications arising from PDPH will be recorded.

Read the detailed description

After obtaining informed consent, eligible patients will be included in the study. Demographic data and headache history will be recorded, and preoperative anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI).

In the operating room, patients will be monitored with electrocardiography, pulse oximetry, non-invasive blood pressure, and Pleth Variability Index (PVI) sensors. Baseline measurements, including peak heart rate (HR), peripheral oxygen saturation (SpO2), systolic (SBP) and diastolic blood pressure (DBP), mean arterial pressure (MAP) and PVI will be recorded. Measurements will be repeated at five-minute intervals for the first 30 minutes of the operation and at 15-minute intervals thereafter.

Following spinal anesthesia, procedural details such as the experience level of the practitioner, patient positioning, needle brand, type and size, number of attempts, puncture level, and anesthetic dose will be documented.

Patients will be monitored periodically for PDPH development. The frequency and severity of headaches will be assessed using the Numerical Rating Scale (NRS) and Wong-Baker Scale. Additionally, the need for medical consultations and any complications arising from PDPH will be recorded.

02

Conditions studied

  • Post-Dural Puncture Headache
03

In context

Post-Dural Puncture Headache

125 studies on the registry are indexed under Post-Dural Puncture Headache; 25 are open to participants now.

This study's enrollment of 112 is below the median of 188 across 34 observational studies indexed under Post-Dural Puncture Headache.

Browse Post-Dural Puncture Headache studies →

Lead sponsor

Duzce University is the lead sponsor of 70 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Obstetric and non-obstetric female patients undergoing spinal anesthesia

Inclusion criteria

  • Female patients aged 18-65 years undergoing surgery under spinal anesthesia
  • Patients classified as ASA I or II according to the American Society of Anesthesiologists (ASA) classification

Exclusion criteria

Exclusion Criteria:

  • ASA III and above patients
  • Patients requiring Intensive Care Unit (ICU) admission
  • Patients with mental retardation
  • Patients with communication difficulties (e.g., hearing loss, speech impediments, language barriers)
  • Conversion to general anesthesia due to pain after spinal anesthesia
  • Emergency surgeries
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
112 participants (actual)
Patient registry
No

Groups and cohorts

  • Obstetric

    56 female obstetric patients undergoing spinal anesthesia

    Procedure: Spinal anesthesia

  • Non-obstetric

    56 female non-obstetric patients undergoing spinal anesthesia

    Procedure: Spinal anesthesia

Interventions

  • ProcedureSpinal anesthesia

    In both groups patients will undergo spinal anesthesia and be followed intra- and postoperatively in the context of postdural puncture headache

06

What researchers measure

Primary outcomes

  1. Headache development for patients who can read and write

    Development of post-dural puncture headache will be assessed using the Numerical Rating Scale (NRS) NRS is a scale between 0 (no pain) and 10 (most severe pain the patient has ever felt in is/her life). It is suitable for patients who can read and write.

    Time frame: 1 time preoperatively in the premedication unit, 1 time per hospitalization day postoperatively up to 7 days and on the 7th, 14th, 21st, and 30th postoperative days after discharge by phone call

  2. Headache development for patients who cannot read and write

    Development of post-dural puncture headache will be assessed using Wong-Baker Faces Pain Rating Scale. The Wong-Baker Faces Pain Rating Scale is a tool that uses a combination of faces and words to help a person effectively communicate the severity of their physical pain. It is suitable for patients who cannot read and write.

    Time frame: 1 time preoperatively in the premedication unit, 1 time per hospitalization day postoperatively up to 7 days and on the 7th, 14th, 21st, and 30th postoperative days after discharge by phone call

Secondary outcomes

  1. Preoperative anxiety

    Preoperative anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI). STAI is a test to assess both state and trait anxiety separately. Each type of anxiety has its own scale of 20 different questions that are scored. Scores range from 20 to 80, with higher scores correlating with greater anxiety.

    Time frame: 1 time preoperatively in the premedication room

  2. Contributing factors: The experience level of the practitioner

    The experience level of the practitioner will be recorded once when dural puncture is performed. It will be assessed as "1-3 years, 3-5 years, 5-10 years and over 10 years of practice".

    Time frame: 1 time intraoperatively

  3. Contributing factors: The patient positioning

    The patient position will be recorded once when dural puncture is performed. It will be assessed as "sitting position, lateral decubitus or prone position".

    Time frame: 1 time intraoperatively

  4. Contributing factors: The needle factors

    Needle brand, type and size will be recorded once when dural puncture is performed.

    Time frame: 1 time intraoperatively

  5. Contributing factors: The number of puncture attempts

    The number of attempts will be recorded once when dural puncture is performed.

    Time frame: 1 time intraoperatively

  6. Contributing factors: The puncture level

    The vertebral level of dural puncture will be recorded once when dural puncture is performed.

    Time frame: 1 time intraoperatively

  7. Contributing factors: The anesthetic dose

    The total dose of local anesthetic drug will be recorded once when spinal anesthesia is performed.

    Time frame: 1 time intraoperatively

07

Study locations

1 site
  • Duzce University Faculty of Medicine
    Düzce, Düzce 81000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06992063
Lead sponsor
Duzce University
Responsible party
Özlem Ersoy Karka (Assistant Professor, Duzce University) — Principal investigator
First posted
May 28, 2025
Start date
May 30, 2025
Primary completion
Jan 1, 2026
Completion
Jan 1, 2026
Last update
May 22, 2026

Study contacts

Özlem Ersoy Karka
study chair · Düzce University Faculty of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion